Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “glucocorticoid”

112 pharma patents match "glucocorticoid" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 112
Index total 30,257
Page 3 / 5

Quick answer

This filtered view shows 112 pharmaceutical patents matching "glucocorticoid" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

112 results for “glucocorticoid” · 30,257 patents in full index Clear search

  1. US 11058670

    Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator

    Corcept Therapeutics Incorporated · Granted Jul 13, 2021 · Expires Jul 8, 2041

    granted

  2. US 11045482

    Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors

    Corcept Therapeutics Incorporated · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted

  3. US 10980797

    Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors

    Corcept Therapeutics Incorporated · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted

  4. US 10973813

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted

  5. US 10933071

    Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Mar 2, 2021 · Expires Feb 25, 2041

    granted

  6. US 10907175

    Isolated human cell with an inactivated glucocorticoid receptor gene

    Sangamo Therapeutics, Inc. · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  7. US 10898478

    Glucocorticoid receptor modulators to treat cervical cancer

    Corcept Therapeutics Incorporated · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  8. US 10881660

    Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists

    Corcept Therapeutics Incorporated · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  9. US 10844129

    Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids

    Inhibrx, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted

  10. US 10842800

    Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

    Corcept Therapeutics Incorporated · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted

  11. US 10836789

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  12. US 10828280

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  13. US 10787449

    Octahydro fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted

  14. US 10780097

    Use of cortisol in assessment and prophylactic treatment of hypokalemia associated with glucocorticoid receptor modulator treatment of Cushing's syndrome patients

    Corcept Therapeutics Incorporated · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  15. US 10723759

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  16. US 10646474

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted May 12, 2020 · Expires May 7, 2040

    granted

  17. US 10610534

    Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency

    Corcept Therapeutics Incorporated · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  18. US 10568880

    Glucocorticoid receptor modulators to treat cervical cancer

    Corcept Therapeutics Incorporated · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  19. US 10485809

    Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  20. US 10472387

    Inhibitors of glucocorticoid receptor

    ORIC PHARMACEUTICALS, INC. · Granted Nov 12, 2019 · Expires Nov 7, 2039

    granted

  21. US 10456392

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Oct 29, 2019 · Expires Oct 24, 2039

    granted

  22. US 10449178

    Glucocorticoid receptor modulators to treat pancreatic cancer

    Corcept Therapeutics Incorporated · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  23. US 10413540

    Glucocorticoid receptor modulators to treat cervical cancer

    Corcept Therapeutics Incorporated · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  24. US 10323034

    Octahydro fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.